Experts say that innovations like microneedle patches, oral formulations, and nasal sprays represent the next phase in immunisation. These painless vaccines deliver antigens effectively without invasive injections. While research continues, current data shows comparable efficacy with reduced distress in infants, improving compliance and vaccine coverage.